CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11,000 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03255109
NCT03255109N/ACompleted

WEAN SAFE (WorldwidE AssessmeNt of Separation of pAtients From Ventilatory assistancE)

European Society of Intensive Care Medicine·observational·Posted Aug 21, 2017·Updated Feb 12, 2019

In Brief

An observational study for Acute Severe Respiratory Failure and Acute Respiratory Distress Syndrome. Completed, enrolled 11,000 participants across 1 site.

Detailed Summary

WEAN SAFE (WorldwidE AssessmeNt of Separation of pAtients From ventilatory assistancE) is a multi-centre, prospective, observational, 4-week inception cohort study being carried out by the Acute Respiratory Failure section of ESICM. Weaning represents a challenge for intensivists and patients spend a considerable amount of time in being liberated from mechanical ventilation. While guidelines do exist on the classification of weaning, a recent study has shown that these may not be applicable to all patients. Moreover, different practices exist in regard to weaning procedures. WEAN SAFE will prospectively assess the burden of, management and spectrum of approaches to weaning from ventilation, in patients that require invasive mechanical ventilation for any reason, for a time period of at least 24 hours.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesBelgium
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 21, 2017
Enrollment StartOct 1, 2017
Primary CompletionMay 31, 2018
Study CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 8.9 years ago